According to clinicaltrials.gov primary completion is July 2023. The study doesn’t complete until March 2025. When the trial was first announced first patient dosing was expected in mid(3qtr) 2021. We are in early 2022 and there has still been no announcement of first patient dosing. By rights an ann should be imminent.
Not sure what the holdup is but may be Covid related, who knows. I wouldn’t be surprised if completion dates slip backwards.
Results wise, Tacti-002 results should make good reading at some point in the first half of this year.
According to clinicaltrials.gov primary completion is July 2023....
-
- There are more pages in this discussion • 2,652 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 41.0¢ | $1.132M | 2.721M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15565 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 246989 | 7 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |